Lakeland Regional Health

863.687.1100

Lakeland Regional Health Cancer Center
Lakeland Regional Health Cancer Center
Lakeland Regional Health Cancer Center

Print Page

Leukemia

Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia.

Clinical Trial # E1912:

  • Ibrutnib and Rituximab vs standard FCR to prolong progression free survival  of  Chronic Lympocytic Leukemia or Small Lymphocytic Leukemia.
  • Participants muse be 18-70 years of age with a performance status of 0-2.  The diagnosis of Chronic Lympocytic Leukemia or Small Lymphocytic Leukemia  must be according to NCI/WCLL or SLL according to WHO criteria.
  • Exclusions include but are not limited to:  Prior chemotherapy or monoclonal antibody therapy,  major surgery within 28 days of registration, radiation therapy < 4 weeks prior to registration, recent Myocardial Infarction or Cerebrovascula Accident.

© 2015 Lakeland Regional Health